Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 4, No 4 (2008) BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST Abstract  similar documents
L. N. Malaj
"... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..."
 
Vol 6, No 6 (2010) THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina
"... concerning the evidence base for effects of various beta-blockers on the outcomes of cardiovascular diseases ..."
 
Vol 6, No 5 (2010) EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY Abstract  similar documents
O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva
"... year worldwide, and cardiovascular complications happen in 500 000 - 900 000 patients. Aim ..."
 
Vol 8, No 4 (2012) HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
V. P. Lupanov
"... improvement and decrease in cardiovascular complications risk. ..."
 
Vol 6, No 1 (2010) THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular ..."
 
Vol 9, No 4 (2013) USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... of risk modification of cardiovascular complications in the perioperative period. Therefore, special ..."
 
Vol 12, No 3 (2016) PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, A. V. Zakharova, M. M. Loukianov, A. N. Vorobyev, K. A. Moseichuk, A. N. Kozminsky
"... frequently prescribed BB was bisoprolol in all cardiovascular diseases. Conclusion. In a specialized medical ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... kidney diseases (CKD) and the development of cardiovascular complications. Immune and non-immune ..."
 
Vol 8, No 4 (2012) EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS Abstract  similar documents
I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze
"... to recommend discussed cardiovascular drugs for prevention of osteoporosis and fractures, as well ..."
 
Vol 12, No 1 (2016) CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova
"... Aim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate ..."
 
Vol 4, No 3 (2008) URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES Abstract  similar documents
M. P. Savenkov, A. S. Volkova, A. V. Kirienko, S. N. Ivanov, S. V. Ivanov
"... of cardiovascular drugs should be considered by practitioners especially in treatment of elderly patients. ..."
 
Vol 7, No 5 (2011) THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman
"... to recommended therapy on the risk of cardiovascular events during a year after hospital admission ..."
 
Vol 15, No 1 (2019) Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength Abstract  similar documents
I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova
"... of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates ..."
 
Vol 13, No 4 (2017) CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA Abstract  similar documents
S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, Yu. V. Lukina, M. M. Loukianov, A. N. Vorobyev, A. N. Kozminsky
"... Aim. To assess the practice of using beta-adrenoblockers (β-AB) in patients with cardiovascular ..."
 
Vol 4, No 2 (2008) DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES Abstract  similar documents
E. V. Shilova, S. Y. Martsevich
"... (STONE, STOP-Hypertension-2, ALLHAT, ASCOT-BPLA etc.) devoted to estimation of CA effects on the risk ..."
 
Vol 1, No 1 (2005) DRUGS AND SMOKING Abstract  similar documents
J. V. Lukina
"... the metabolism of drugs. The number of researches showed decrease in efficacy of some cardiovascular drugs ..."
 
Vol 5, No 3 (2009) RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov
"... to provide high level of compliance in patients with cardiovascular diseases. ..."
 
Vol 5, No 1 (2009) SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova
"... – arterial hypertension (HT) and hypercholesterolemia (HH) in patients with high risk of cardiovascular ..."
 
Vol 15, No 5 (2019) Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris Abstract  similar documents
V. V. Kashtalap, O. L. Barbarash, D. Yu. Sedykh, K. E. Krivoshapova, D. P. Tsygankova, O. V. Tsygankova
"... was performed at the Research Institute for Complex Issues of Cardiovascular Diseases. The study included 50 ..."
 
Vol 16, No 1 (2020) High Blood Pressure Variability is an Additional Cardiovascular Risk Factor Abstract  similar documents
A. V. Rodionov
"... that increased BP variability is an independent prognostic factor that increases the risk of cardiovascular ..."
 
Vol 3, No 3 (2007) STRESS: WHAT WE ACTUALLY KNOW ABOUT THIS RISK FACTOR? Abstract  similar documents
R. G. Oganov, G. V. Pogosova
"... Results of current studies devoted to relationship between stress and cardiovascular morbidity ..."
 
Vol 12, No 2 (2016) ENDOTHELIAL DYSFUNCTION AND ROLE NITRATES AND BETA-BLOCKERS IN ITS CORRECTION IN ISCHEMIC HEART DISEASE Abstract  similar documents
A. N. Britov
"... cardiovascular diseases is considered. The endothelial dysfunction takes place at the earliest stages of diseases ..."
 
Vol 8, No 1 (2012) BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE Abstract  similar documents
M. V. Leonova
"... Представлены данные наиболее крупных мета-анализов применения бета-адреноблокаторов (БАБ) при ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... prevention of cardiovascular diseases in patients with a history of myocardial infarction in ambulatory ..."
 
Vol 16, No 6 (2020) Adherence to Clinical Quidelines on Preoperative Assessment and Correction of Cardiovascular Risk in Non-cardiac Surgery Abstract  similar documents
M. D. Nigmatkulova, E. B. Kleymenova, L. P. Yashina, V. A. Otdelenov, S. A. Payushchik, O. D. Konova, D. A. Sychev
"... пациентов и периоперационное ведение, терапия бета-адреноблокаторами, ингибиторами 3-гидрокси-3 ..."
 
Vol 8, No 5 (2012) THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN Abstract  similar documents
R. I. Striuk, Ya. V. Brytkova
"... Highly selective β-adrenoblockers (β-AB) are used in pregnant women with cardiovascular diseases ..."
 
Vol 6, No 5 (2010) WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT? Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov
"... -адреноблокаторами (БАБ). Пациенты были рандомизированы на 3 группы в зависимости от принимаемого БАБ: 1-я группа (n ..."
 
Vol 6, No 4 (2010) HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE Abstract  similar documents
G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov
"... The correlation of age-dependent reduction in sex hormones level and changes of cardiovascular ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
 
Vol 1, No 1 (2005) MENOPAUSE AND CARDIOVASCULAR RISK Abstract  similar documents
D. A. Anichkov, N. A. Shostak, A. D. Zhuravleva
"... A role of menopause as a cardiovascular risk factor is reviewed. Menopause influence ..."
 
Vol 14, No 6 (2018) Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation Abstract  PDF (Eng)  similar documents
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee
"... Aim. To evaluate the availability and affordability of medicines used to treat of cardiovascular ..."
 
Vol 11, No 1 (2015) VASCULAR COMORBIDITY: GENERAL APPROACHES TO PREVENTION AND TREATMENT Abstract  PDF (Eng)  similar documents
R. G. Oganov
"... The problem of vascular comorbidity in patients with cardiovascular diseases, its effect ..."
 
Vol 13, No 3 (2017) SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION Abstract  similar documents
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
"... Aim. To study secondary prevention of cardiovascular diseases among patients of different age ..."
 
Vol 16, No 4 (2020) Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues Abstract  similar documents
M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova
"... in a significant proportion of patients with atherosclerotic cardiovascular diseases (ACVD) is impossible ..."
 
Vol 9, No 1 (2013) EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS Abstract  similar documents
E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov
"... growth rate of mortality. Glucose blood levels should be monitored to reduce the risk of cardiovascular ..."
 
Vol 4, No 1 (2008) WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL Abstract  similar documents
M. N. Mamedov, M. B. Stroeva
"... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..."
 
Vol 14, No 2 (2018) DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT Abstract  similar documents
N. В. Perepech, A. V. Tregubov
"... for primary and secondary prevention of cardiovascular diseases. 276 questionnaires filled out by 185 ..."
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... Aim. To evaluate the frequency of the prescription of cardiovascular drugs in patients before ..."
 
Vol 10, No 4 (2014) QUALITY ASSESSMENT OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION WITHOUT CONCOMITANT CARDIOVASCULAR DISEASES AS A PART OF OUTPATIENT RECVASA REGISTER Abstract  similar documents
A. V. Zagrebelnyy, S. Yu. Martsevich, M. M. Loukianov, E. A. Pravkina, A. N. Vorobyev, S. S. Yakushin, S. A. Boytsov
"... назначенных АГП, относили АГП к определенному классу. На примере бета-адреноблокаторов (ББ) оценивали ..."
 
Vol 9, No 5 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... prescription frequency of drugs with proven effects on the cardiovascular risk in patients with stable IHD ..."
 
Vol 6, No 5 (2010) LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? Abstract  similar documents
I. V. Zhirov
"... with cardiovascular diseases are presented. The main practical ways to reduce the possible gastrointestinal ..."
 
Vol 7, No 6 (2011) DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova
"... logistic regression. Results. Awareness of the cardiovascular diseases (CVD) and its prevention (odds ratio ..."
 
Vol 9, No 3 (2013) STATINS AND RISK OF INFECTIOUS DISEASES Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
 
Vol 9, No 4 (2013) STATINS IN PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
 
Vol 9, No 4 (2013) NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY Abstract  similar documents
A. V. Rudenko, B. A. Rudenko
"... cardiovascular events incidence in patients with atherosclerosis, even if they have no arterial hypertension ..."
 
Vol 11, No 6 (2015) Alcohol consumption in patients with cardiovascular diseases (results of the survey of cardiac patients in outpatient practice) Abstract  similar documents
O. D. Ostroumova, I. E. Nikolaeva, S. Ya. Eregin, I. V. Pokrovskaya, K. A. Ishchenko
"... Aim. To study the frequency and characteristics of alcohol use in outpatients with cardiovascular ..."
 
Vol 5, No 4 (2009) PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... The definition of primary prevention of cardiovascular diseases is presented. Statins preventive ..."
 
Vol 5, No 6 (2009) EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) Abstract  similar documents
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko
"... with different cardiovascular risk (according to arterial hypertension (HT) risk stratification) in real clinical ..."
 
Vol 10, No 5 (2014) STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... modification of cardiovascular complications in the perioperative period. Particular attention has recently ..."
 
Vol 1, No 3 (2005) RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS Abstract  similar documents
D. A. Anichkov, N. A. Shostak
"... The cardiovascular risk factors in patients with rheumatoid arthritis (RA) are reviewed ..."
 
Vol 16, No 5 (2020) Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register Abstract  similar documents
I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova
"... 5694 пациента, последовательно госпитализированных в Региональный сосудистый центр в период с 01 ..."
 
Vol 16, No 4 (2020) Epicardial Adipose Tissue as a New Target of Therapeutic Interventions Abstract  similar documents
M. A. Druzhilov, T. Y. Kuznetsova
"... be considered as a potentially modifiable factor of cardiovascular risk, the various therapeutic interventions ..."
 
Vol 8, No 3 (2012) MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
"... in different cardiovascular diseases are obtained. Physiological significance of magnesium is determined by its ..."
 
Vol 15, No 5 (2019) The Concept of Early Vascular Aging Abstract  similar documents
N. V. Burko, I. V. Avdeeva, V. E. Oleynikov, S. A. Boytsov
"... the development of cardiovascular events in young people. This phenomenon is described as a syndrome of early ..."
 
Vol 14, No 6 (2018) Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, O. M. Drapkina, A. N. Vorobyev, A. V. Zagrebelnyy, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Okshina, E. V. Kudryashov, E. N. Belova, V. G. Klyashtorny, S. A. Boytsov
"... Aim. To evaluate the structure of combined cardiovascular diseases, drug treatment and observation ..."
 
Vol 5, No 1 (2009) ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT? Abstract  similar documents
S. Y. Martsevich
"... , сравнивавших влияние ББ и других классов антигипертензивных препаратов на вероятность сердечно-сосудистых ..."
 
Vol 5, No 2 (2009) COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
"... Цель. Сравнить два варианта терапии бета-адреноблокаторами (БАБ), основанных на карведилоле или ..."
 
Vol 14, No 5 (2018) Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... data, the type and duration of AF, cardiovascular diseases (CVD), concomitant noncardiac pathology ..."
 
Vol 13, No 6 (2017) SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis Abstract  similar documents
O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina
"... of acute cardiovascular events during smoking include the activation of inflammation, platelet aggregation ..."
 
Vol 9, No 1 (2013) CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE Abstract  similar documents
M. I. Shupina, O. Ju. Korennova, E. N. Loginova
"... . The total cardiovascular risk in patients of “Health school” and "Typical practice" groups after 12 months ..."
 
Vol 10, No 1 (2014) MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT Abstract  similar documents
E. I. Trisvetova
"... Progression of cardiovascular disease is often caused by a deficiency of magnesium in the human ..."
 
Vol 8, No 5 (2012) ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? Abstract  similar documents
S. A. Boldueva, I. A. Leonova
"... and the main indications are discussed. ASA use for primary cardiovascular diseases prevention and its possible ..."
 
Vol 5, No 1 (2009) CARDIOLOGICAL MANAGEMENT OF PREGNANT WOMEN IN THE UDMURT REPUBLIC Abstract  similar documents
I. R. Gaisin, R. M. Valeeva, L. V. Shilina, N. Yu. Chernisheva, N. I. Maksimov
"... Aim. To assess the efficacy of specialized management of pregnant women with cardiovascular ..."
 
Vol 5, No 3 (2009) CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE Abstract  similar documents
A. V. Kontsevaya, A. M. Kalinina, Yu. M. Pozdnyakov, S. V. Belonosova, M. B. Khudyakov
"... Aim. To study clinical and economical rationales for cardiovascular risk evaluation at workplace ..."
 
Vol 12, No 3 (2016) REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko
"... of various cardiovascular diseases (CVD) were among participants of the meeting. The importance of modern ..."
 
Vol 12, No 4 (2016) Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk Abstract  PDF (Eng)  similar documents
F. I. Belyalov, I. V. Samorodskaya, S. V. Pogodaeva
"... Aim. To study standardized all-cause mortality and cardiovascular mortality (or deaths due ..."
 
Vol 11, No 5 (2015) Perioperative assessment of troponin level in the non-cardiac interventions: is there such a need? Abstract  similar documents
A. N. Sumin
 
Vol 12, No 1 (2016) Effect of magnesium on the cardiovascular system in women Abstract  PDF (Eng)  similar documents
E. A. Ulubieva, A. G. Avtandilov
"... Recent scientific data on the influence of magnesium on the cardiovascular and reproductive system ..."
 
Vol 6, No 3 (2010) BLUMENTHAL SCREENING FOR CARDIOVASCULAR RISK IN ASYMPTOMATIC PATIENTS Abstract  similar documents
J. S. Berger, C. O. Jordan, D. Lloyd-Jones, R.S. Blumenthal
"... Blumenthal screening for cardiovascular risk in asymptomatic patients. ..."
 
Vol 15, No 2 (2019) Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics Abstract  similar documents
G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov
"... high and extremely high cardiovascular risk. The indication for the pharmacological treatment to reduce ..."
 
Vol 3, No 1 (2007) THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION Abstract  similar documents
D. B. Nebieridze, A. S. Safaryan
 
Vol 13, No 1 (2017) THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS Abstract  similar documents
O. M. Drapkina, R. N. Shepel
"... of the cardiovascular system. Its connections to the increased incidence of myocardial infarction, stroke ..."
 
Vol 13, No 3 (2017) ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) Abstract  PDF (Eng)  similar documents
O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov
"... Aim. To study the relationship of individual cardiovascular risk factors with arterial stiffness ..."
 
Vol 14, No 1 (2018) SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking Abstract  similar documents
O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva
"... reduces the risk of developing stable and unstable angina, acute myocardial infarction, cardiovascular ..."
 
Vol 7, No 4 (2011) METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE Abstract  similar documents
M. S. Berezhnova
"... of cardiovascular disease. There are a lot of approaches to drop smoking including innovative pharmacotherapy ..."
 
Vol 6, No 5 (2010) PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE Abstract  similar documents
M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva
"... of ED in the majority of men (about 80% of patients) is cardiovascular diseases (atherosclerosis ..."
 
Vol 11, No 3 (2015) OMEGA-3 FATTY ACIDS AND AGE-RELATED DISEASES: REALITIES AND PROSPECTS Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
"... acids are included into the treatment protocols for patients with cardiovascular diseases ..."
 
Vol 11, No 2 (2015) LOW SODIUM DIET: PROS AND CONS Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
 
Vol 10, No 1 (2014) ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES Abstract  similar documents
J. D. Kobalava, Yu. V. Kotovskaya, S. V. Villevalde, A. E. Soloveva, I. M. Amirbegishvili
"... Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD ..."
 
Vol 10, No 4 (2014) MODERN PRINCIPLES OF QUALITY ASSESSMENT OF CARDIOVASCULAR DISEASES TREATMENT Abstract  similar documents
A. Yu. Suvorov, S. Yu. Martsevich
"... The most common ways of assessment of cardiovascular diseases treatment abroad, approaches ..."
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... cardiovascular diseases is one of the priorities of modern medicine. This therapy usually consists of several ..."
 
Vol 5, No 1 (2009) CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. A. Anichkov, A. A. Platonova
"... association between HRV indexes and cardiovascular risk factors and RA-related clinical characteristics ..."
 
Vol 5, No 4 (2009) COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS Abstract  PDF (Eng)  similar documents
N. A. Karoli, A. P. Rebrov
"... Aim. To study prevalence and features of cardiovascular diseases (arterial hypertension, ischemic ..."
 
Vol 4, No 4 (2008) CARDIOVASCULAR EVENT RISK REDUCTION WITH MEDICINES: DATA OF EVIDENCE BASED MEDICINE AND RECOMMENDATIONS TO PRACTITIONERS Abstract  similar documents
S. Y. Martsevich
"... Cardiovascular event risk reduction with medicines is discussed in the article. The role ..."
 
Vol 15, No 4 (2019) Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare Abstract  similar documents
O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel
"... of cardiovascular complications for primary prevention in a wide population are presented. The question of the ratio ..."
 
Vol 12, No 5 (2016) The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies Abstract  similar documents
E. K. Butina, E. V. Bochkareva
"... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..."
 
Vol 1, No 1 (2005) ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES Abstract  similar documents
Y. A. Karpov
"... risk due to cardiovascular reasons. Favorable therapeutic effects of inhibiting RAS activity ..."
 
Vol 16, No 4 (2020) Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice Abstract  similar documents
D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan
"... to cardiovascular risk require an optimization of their pharmacotherapy in clinical practice. Aim. To study ..."
 
Vol 5, No 2 (2009) DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov
"... which treat and follow-up patients with cardiovascular diseases (CVD). Material and methods ..."
 
Vol 4, No 5 (2008) MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM Abstract  similar documents
I. Yu. Torshin, O. A. Gromova
"... of orotic acid and magnesium orotate on cardiovascular system as well as therapeutic implementation ..."
 
Vol 13, No 3 (2017) ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, M. V. Pisarev
"... important mechanisms for the realization of the cardiovascular continuum. The role that angiotensin receptor ..."
 
Vol 9, No 4 (2013) VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... The problem of varenicline use in patients with cardiovascular diseases is discussed. Results ..."
 
Vol 14, No 2 (2018) ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 Abstract  PDF (Eng)  similar documents
A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov
"... Aim. To evaluate the economic burden of cardiovascular diseases (CVD) in the Russian Federation ..."
 
Vol 3, No 4 (2007) GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES Abstract  similar documents
L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir
"... The Task Force on Diabetes and Cardiovascular diseases of the European Society of Cardiology ..."
 
Vol 3, No 5 (2007) GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES Abstract  similar documents
L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, K. Malmberg, S. Priori, J. Ostergren, J. Tuomilehto, I. Thrainsdottir
"... The Task Force on Diabetes and Cardiovascular diseases of the European Society of Cardiology ..."
 
Vol 15, No 3 (2019) Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
 
Vol 1, No 3 (2005) EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE Abstract  similar documents
G. De Backer, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, J. Dallongeville, S. Ebrahim, O. Faergeman, I. Graham, G. Mancia, V. Manger Cats, K. Orth-Gomer, J. Perk, K. Pyorala, J. Rodicio, S. Sans, V. Sansoy, U. Sechtem, S. Silber, T. Thomsen, D. Wood
"... European guidelines on cardiovascular disease prevention in clinical practice. ..."
 
Vol 16, No 5 (2020) Possible Approaches to Primary Prevention of Cardiovascular Diseases Abstract  similar documents
V. N. Larina, D. S. Mkrtychev, V. A. Kuznetsova, A. A. Tyazhelnikov
"... with the development of cardiovascular diseases (CVD), allowed the experts of the American Heart Association to develop ..."
 
Vol 3, No 4 (2007) EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE Abstract  similar documents
A. N. Zakirova, N. E. Zakirova, I. M. Karamova, N. Kh. Khafizov, O. V. Rasskazova
"... Цель. Установить влияние β-адреноблокаторов (БАБ) на ремоделирование миокарда ..."
 
Vol 15, No 3 (2019) Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases Abstract  similar documents
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina
"... the stratification of cardiovascular risk in the female population are of increasing interest. The purpose of the 2 ..."
 
1 - 100 of 678 Items 1 2 3 4 5 6 7 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)